Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.410
+0.030 (2.17%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Allarity Therapeutics Market Cap
Allarity Therapeutics has a market cap or net worth of $22.43 million as of August 28, 2026. Its market cap has decreased by -3.49% in one year.
Market Cap
22.43M
Enterprise Value
27.74M
1-Year Change
-3.49%
Ranking
Category
Stock Price
$1.41
ChartMarket Cap Chart
Since December 21, 2021, Allarity Therapeutics's market cap has decreased from $79.38M to $22.43M, a decrease of -71.74%. That is a compound annual growth rate of -23.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 22.43M | 31.45% |
| Dec 31, 2025 | 17.07M | 229.00% |
| Dec 31, 2024 | 5.19M | 106.50% |
| Dec 29, 2023 | 2.51M | -40.12% |
| Dec 30, 2022 | 4.20M | -94.65% |
| Dec 31, 2021 | 78.43M | -1.20% |
| Dec 21, 2021 | 79.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tvardi Therapeutics | 24.28M |
| Dyadic International | 24.14M |
| Cellectar Biosciences | 23.72M |
| Jasper Therapeutics | 23.52M |
| Cerenome | 22.88M |
| Longeveron | 22.63M |
| Niki BioSolutions | 22.63M |
| Cocrystal Pharma | 21.86M |